trending Market Intelligence /marketintelligence/en/news-insights/trending/2ez7kai_ouz09bohlkhn0a2 content esgSubNav
In This List

Heat Biologics regains Nasdaq compliance

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Heat Biologics regains Nasdaq compliance

Heat Biologics Inc. said it regained compliance with Nasdaq Stock Market's minimum bid price requirement of $1 per share.

The Durham, N.C.-based company implemented a 1-for-10 reverse stock split of its common shares to regain compliance with Nasdaq's listing rule.